top of page

Recommendations

Medical Consultation

Inefficiencies and gaps in optimizing patient entry into diagnosis systems in Canada abound and there are many opportunities for improvement. Action must be taken by policy makers and those working in cancer control in Canada to improve the cancer diagnosis process for all Canadians.

In this section, we present a set of key recommendations to improve the swiftness, accuracy and appropriateness of communication of the diagnosis process in Canada. 

 

Recommendations have been written so that they remain relevant given the uncertain, but potentially major and long-lasting, impacts on the health care system of the COVID-19 pandemic

Our Key Recommendations

Recommendation #1

National convening and coordination of the efforts of various stakeholders in implementing these recommendations are required, with patients and patient representatives providing meaningful leadership in any ongoing multi-stakeholder implementation efforts.

Receptionist

Led by patient groups and those with lived cancer experience, All.Can Canada is a national platform focused on improving cancer diagnosis. It aims to streamline access to timely, accurate, and appropriately delivered diagnoses. All.Can Canada engages government stakeholders, health authorities, healthcare providers, and patient organizations to share key findings and resources with the diagnosis ecosystem to improve patient outcomes.

Led by patient groups and people with lived experiences of cancer, AllCan Canada is a national, multi-stakeholder platform fo

Sign up for our newsletter.

  • Facebook
  • LinledIn
  • YouTube

The head office of Save Your Skin Foundation, the Secretariat of All.Can Canada, is located on the traditional unceded territory of the Syilx Okanagan Nation. The Save Your Skin Foundation and All.Can Canada staff, board, and community are grateful to the Okanagan people, who are the stewards of these beautiful lands.

 

All.Can Canada is an initiative of Save Your Skin Foundation, a not-for-profit organisation registered in Canada. Its work is made possible with financial support from Bristol Myers Squibb, Merck, Novartis, Pfizer, Johnson & Johnson, AstraZeneca, Amgen, and Medison.

Charitable Reg. #857756589R

bottom of page